Application 078151
- Type
- ANDA
- Sponsor
- AKORN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TERBUTALINE SULFATE | TERBUTALINE SULFATE | INJECTABLE;INJECTION | 1MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078151-001 | TERBUTALINE SULFATE | TERBUTALINE SULFATE | 1MG/ML | INJECTABLE / INJECTION | 2008-01-07 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A078151-001 | TERBUTALINE SULFATE | 1MG/ML | INJECTABLE / INJECTION | 2008-01-07 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A078151-001 | TERBUTALINE SULFATE | 1MG/ML | INJECTABLE / INJECTION | AP | 2008-01-07 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A078151-001 | TERBUTALINE SULFATE | 1MG/ML | INJECTABLE / INJECTION | 2008-01-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078151-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A078151-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A078151-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A078151-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A078151-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A078151-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A078151-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A078151-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A078151-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A078151-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A078151-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A078151-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A078151-001 | AP | 1 | ea99ee380514… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A078151-001 | AP | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Terbutaline Sulfate | TERBUTALINE SULFATE | Chartwell RX, LLC. | 859267c6-3d14-4123-9b9d-4fc248f09726 | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | Terbutaline Sulfate TERBUTALINE SULFATE |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Upsher-Smith Laboratories, LLC | 3a4e5046-293c-4616-8679-6da65f31626b | 2025-08-27 | Boxed warning, Warnings, Adverse reactions | Terbutaline Sulfate TERBUTALINE SULFATE |
| TERBUTALINE SULFATE | TERBUTALINE SULFATE | Amneal Pharmaceuticals of New York LLC | 382dcebb-6e41-4335-818d-b5822e3fb884 | 2025-07-29 | Boxed warning, Warnings, Adverse reactions | TERBUTALINE SULFATE TERBUTALINE SULFATE |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Henry Schein, Inc. | 9f4b177e-4d7d-4255-afeb-522c7d4594c6 | 2025-07-16 | Warnings, Adverse reactions | Terbutaline Sulfate TERBUTALINE SULFATE |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Hikma Pharmaceuticals USA Inc. | 613df3cb-4d55-4d12-ab08-a932481aaa0b | 2024-01-04 | Boxed warning, Warnings, Adverse reactions | Terbutaline Sulfate TERBUTALINE SULFATE |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Medical Purchasing Solutions. LLC | 6a22b62c-4ee1-49df-e053-2a91aa0a3e52 | 2023-05-23 | Boxed warning, Warnings, Adverse reactions | Terbutaline Sulfate TERBUTALINE SULFATE |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Fresenius Kabi USA, LLC | cec31032-f366-4524-9e01-63146e473b2b | 2022-07-12 | Boxed warning, Warnings, Adverse reactions | Terbutaline Sulfate TERBUTALINE SULFATE |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Proficient Rx LP | 0a95bc4f-34d3-4b5e-841b-6839e1c1e0c7 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | Terbutaline Sulfate TERBUTALINE SULFATE |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Lannett Company, Inc. | fbf54709-5857-4dbc-9233-ebd7abff88c8 | 2020-11-12 | Boxed warning, Warnings, Adverse reactions | Terbutaline Sulfate TERBUTALINE SULFATE |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Hikma Pharmaceuticals USA Inc. | 0f4d3249-e022-40b6-b93d-f605e8522207 | 2020-10-01 | Boxed warning, Warnings, Adverse reactions | Terbutaline Sulfate TERBUTALINE SULFATE |
| Terbutaline Sulfate | TERBUTALINE SULFATE | ANI Pharmaceuticals, Inc. | d810a15b-3e10-4f6c-a36e-8ddecbaba9c3 | 2019-11-15 | Boxed warning, Warnings, Adverse reactions | Terbutaline Sulfate TERBUTALINE SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 17478-933 | Terbutaline Sulfate | Terbutaline Sulfate | Akorn | ANDA | Current |
| 17478-933 | Terbutaline Sulfate | Terbutaline Sulfate | Akorn | ANDA | Current |
| 17478-933 | Terbutaline Sulfate | Terbutaline Sulfate | Akorn | ANDA | Current |
| 17478-933 | Terbutaline Sulfate | Terbutaline Sulfate | Akorn | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 44373 | ORIG | 2011-02-17 |